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doi:10.1016/j.ejvs.2008.12.026Abstract Aim: This study investigated the fate of the stent inner surface in carotid artery
stenting (CAS). In addition, the occurrence of late cerebral micro-embolism after CAS has been
studied in order to identify predictors and correlate it with a possible neo-intimal layer.
Methods: A series of patients were evaluated before CAS through aortic arch trans-oesopha-
geal echocardiography. Six months after CAS, the stent coverage by neo-intima and the
possible presence of uncovered plaques were determined by high-resolution duplex scanning
(5e17-Hz probe and 3D reconstruction). Possible micro-embolic signals (MESs) were evalu-
ated through transcranial duplex scanning (30-min analysis of ipsilateral middle cerebral
artery with a 1e4-Hz probe) and correlated with patients’ characteristics, intimal media
thickness (IMT) (>0.9 mm vs. <0.9 mm) and uncovered proximal plaques, type of stent
(closed vs. open cells) and aortic arch complicated plaques (>4 mm). Fisher’s and Wilcoxon
tests were used to evaluate differences across groups for categorical and continuous
variables, respectively.
Results: In the 68 CASs examined (40 closed cells and 28 open cells), the stent was
completely covered by neo-intima in 52 cases (76.4%). Complete coverage was significantly
correlated with IMT< 0.9 mm and the absence of a proximal plaque uncovered by the stent
(100% vs. 0%, p< 0.001). Hypertension was an independent predictor of complete intimal
coverage (pZ 0.002), while the stent type did not influence this process. The MESs were
significantly more frequent in patients with complicated aortic arch plaques (62.5% vs.
23.8%, p< 0.012), independently from all other factors.MD, Chirurgia Vascolare, Universita` di Bologna, Policlinico S. Orsola Malpighi, Via Massarenti 9, 40138
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520 G.L. Faggioli et al.Table 1 Characteristics of the s
Age, years
Gender, male
Hypertension
Coronary artery disease
Chronic obstructive pulmonary dis
Dyslipidemia
Diabetes mellitus
Current smoking
Chronic renal
failure (GFR< 60 ml/min)
Complicated aortic arch plaque
Preoperative symptoms
Ulcerated or disomogenous plaqueConclusions: The extent of the stent neo-intimal formation is independent of stent type, but
it is correlated with proximal plaque coverage. Six months after CAS, MESs are still possible
and are not prevented by complete neo-intimal stent coverage. Complicated aortic arch
atherosclerosis is an independent predictor of late MES, thus underlying its importance in
cerebral ischaemia onset.
ª 2009 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Carotid artery stenting (CAS) has been proposed as an
alternative to carotid endarterectomy in symptomatic
patients at high surgical risk; however, this procedure may
cause significant peri- and post-procedural cerebral micro-
embolism, even in clinically uneventful cases. Subsequent
pseudo-intimal coverage of the stent may theoretically
prevent late plaque embolism; however, the ultimate fate
of the stent inner surface, with particular attention to
a neo-intimal formation, has been scarcely studied in the
literature. Thus, the first aim of this study was to evaluate
the process of the stent neo-intimal coverage over time and
its determinants.
The second aim was to investigate the risk factors for
micro-embolic events late after CAS as assessed through
the evaluation of micro-embolic signals (MESs) at trans-
cranial duplex scanning. In particular, since ‘complex’
aortic arch plaques detected at trans-oesophageal echo-
cardiography (TEE) have been documented as a strong
independent risk factor for brain infarcts in the general
population,1e11 we decided to investigate the prognostic
role of aortic arch atherosclerosis together with other
clinical and stent-related variables on the occurrence of
late MES after CAS.
Methods
A series of patients consecutively undergoing CAS were
prospectively evaluated before and 6 months after the
procedure, after appropriate informed consent. Aortic arch
atherosclerosis was preoperatively evaluated, 1e3 days
before CAS, through aortic arch TEE using a Hewlett-Packard
Sonos 5500 sonograph (Hewlett-Packard) Philips Medicaltudy population
N (68 pts) %
75.9 3.6 (SD)
48 70.6
54 79.4
22 32.3
ease 4 5.9
24 35.3
12 17.6
4 5.9
10 14.7
22 32.3
0 0.0
23 33.8Systems, Andover, MA, USA with a multiplane trans-oeso-
phageal probe (patients received oropharyngeal local
anaesthetic and mild sedation with intravenous (IV) mid-
azolam). Atherosclerotic aortic arch plaques seen at TEE
were categorised as ‘complicated’ in the presence of mobile
debris or an endoluminal protrusion>0.5 mm; other plaques
were considered ‘uncomplicated’.12
Independently from the TEE results, CAS was then
performed as previously described.13 Briefly, patients were
taken to the angiographic suite after appropriate informed
consent and cardiological evaluation and medicated with
aspirin 100 mg and clopidogrel 75 mg for 3 days before the
procedure. All procedures were performed under local
anaesthesia, systemic heparinisation and an 8F groin
introducer. Common carotid cannulation was achieved
with 40 Boston Scientific or Medtronic HS I and II
catheters over a Terumo stiff guide wire. When cannu-
lation was not achievable by these means, several
different alternative techniques were used (i.e., buddy
wire, coaxial). Brachial or carotid access was not
attempted in any case. Routine cerebral protection was by
Filterwire EZ (Boston Scientific), Angioguard RX (Cordis)
or Accunet RX (Guidant) and stenting by closed-cell
(Wallstent, Boston Scientific) or open-cell stent (Precise,
Cordis or Acculink, Guidant). ‘Technical success’ was
defined as the ability of treating the stenosis with less than
30% residual stenosis. Neurological outcome was evaluated
both at the end of the procedure and in the following 24 h
by a neurologist according to the NIH stroke scale and the
modified Rankin scale.Figure 1 Bidimensional and 3D reconstruction of CAS with
complete pseudo-intimal coverage. The thickness of intima
proximal to the stent is <0.9 mm (precisely 0.7 mm), and a thin
intima lining is clearly visible for the stent length.
Figure 2 Bidimensional and 3D reconstruction of CAS with
complete pseudo-intimal coverage. The thickness of intima
proximal to the stent is <0.9 mm (precisely 0.7 mm), and a thin
intima lining is clearly visible for the stent length.
Figure 4 Bidimensional and 3D reconstruction of CAS with no
pseudo-intimal layer. The thickness of intima proximal to the
stent exceeds 0.9 mm (precisely 1.123 mm), as calculated by
the duplex software.
Table 2 Characteristics of the study population according
to the presence or absence of stent coverage
Stent coverage pa
No
(nZ 16, 23.6%)
Yes
(nZ 52, 76.4%)
Age, years 76.2 (5.3) 75.8 (3.0) 0.7
Male gender 87.5 65.4 0.12
Hypertension 50.0 88.5 0.002
Coronary artery
disease
37.5 30.8 0.8
Chronic obstructive
pulmonary disease
0.0 7.7 0.6
Dyslipidemia 37.5 34.6 0.9
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Six months after CAS, the carotid bifurcation was examined
by high-resolution duplex scanning (Philips IU 22, 5e17-Hz
probe and software Q-LAB for 3D reconstruction). The
percentage of the stent covered by a neo-intimal layer was
calculated by the length divided by length percentage in
four different projections. A stent coverage >80% was
categorised for the subsequent statistical analysis as
‘complete stent coverage’, since we have noted that the
stent covered for over 80% of their surface after 6 months,
becomes completely covered within 1 year.14 ‘Uncovered
plaque’ was defined as the lack of stent coverage of an
evident atherosclerotic plaque. The intimal thickness of
the common carotid artery proximally to the stent was
arbitrarily categorised as >0.9 mm or <0.9 mm. For the
purpose of subsequent statistical analysis, the presence of
uncovered proximal plaque and an intimal thickness
>0.9 mm were considered together. These findings,
together with other characteristics (epidemiology, type of
stent, and type of carotid plaque) were correlated with
complete stent coverage.Figure 3 Bidimensional and 3D reconstruction of CAS with no
pseudo-intimal layer. The thickness of intima Intima thickness
proximal to the stent exceeds 0.9 mm (precisely 1.123 mm), as
calculated by the duplex software.Late micro-embolic events
Possible MESs have been evaluated through transcranial
duplex scanning (TCD). The procedure was performed by
a single operator (MF), blinded to the TEE results, throughDiabetes mellitus 0.0 23.1 0.055
Current smoking 12.5 3.8 0.2
Chronic renal
failure
(GFR< 60 ml/min)
0.0 19.2 0.10
Complicated aortic
arch plaque
37.5 30.8 0.8
Ulcerated or
disomogenous
carotid plaque
43.7 30.7 0.5
Type of stent,
closed cells
62.5 69.2 0.8
Common carotid
intimal
thickness >0.9 mm
100 0.0 <0.001
Where not expressively stated, values are reported as
percentages.
a Fisher’s exact and KruskaleWallis test were used for cate-
gorical and continuous variables, respectively.
Table 4 Characteristics of the study population according
to the presence or absence of complicated plaques in the
aortic arch
Complicated aortic plaques pa
Yes
(nZ 22, 32.3%)
No
(nZ 46, 67.7%)
Age, years (SD) 76.5 (3.1) 75.6 (3.8) 0.2
Age class, >75 years 63.6 47.8 0.3
Male gender 54.5 78.3 0.053
Hypertension 72.7 82.6 0.4
Coronary artery
disease
54.6 21.7 0.012
Chronic obstructive
pulmonary disease
9.1 4.3 0.6
Dyslipidemia 54.6 26.1 0.031
Diabetes mellitus 27.3 13.0 0.2
Current smoking 0.0 8.7 0.3
Chronic renal
failure
(GFR< 60 ml/min)
9.1 17.4 0.5
Ulcerated or
disomogenous
carotid plaque
36.3 32.6 0.8
Type of stent,
closed cells
81.8 60.9 0.10
Common carotid
intimal
thickness >0.9 mm
27.3 21.7 0.8
Complete stent
coverage (>80%)
72.7 78.3 0.8
Where not expressively stated, values are reported as
percentages.
a Fisher’s exact and KruskaleWallis test were used for cate-
gorical and continuous variables, respectively.
Table 3 Characteristics of the study population according
to the presence or absence of micro-cerebral embolisma
Micro-cerebral embolism pb
Yes
(nZ 16, 27.6%)
No
(nZ 42, 72.4%)
Age, years (SD) 75.1 (1.9) 76.6 (3.9) 0.2
Age class, >75 years 50.0 57.1 0.8
Male gender 75.0 71.4 0.9
Hypertension 75.0 85.7 0.4
Coronary artery
disease
37.5 28.6 0.5
Chronic obstructive
pulmonary disease
0.0 9.5 0.6
Dyslipidemia 37.5 33.3 0.8
Diabetes mellitus 12.5 23.8 0.5
Current smoking 0.0 4.8 0.9
Chronic renal
failure
(GFR< 60 ml/min)
12.5 19.0 0.7
Complicated aortic
arch plaque
62.5 23.8 0.012
Ulcerated or
disomogenous
carotid plaque
37.5 35.7 0.9
Type of stent,
closed cells
75 57.1 0.5
Common carotid
intimal
thickness >0.9 mm
12.5 23.8 0.5
Complete stent
coverage (>80%)
87.5 76.2 0.5
Where not expressively stated, values are reported as
percentages.
a For 10 patients, it was not possible to determine the micro-
embolism pattern.
b Fisher’s exact and KruskaleWallis test were used for cate-
gorical and continuous variables, respectively.
522 G.L. Faggioli et al.a 30-min analysis of the ipsilateral middle cerebral artery
with a 1e4-Hz probe. MESs were defined as high-intensity,
transient, unidirectional signals that occurred randomly
within the spectral display, in accordance with the criteria
of the Consensus Committee of the Ninth Cerebral Hemo-
dynamic Symposium.1,15,16 The presence of MES detected
during the 30-min TCD was correlated with patients’ char-
acteristics, intimal media thickness (IMT) (>0.9 mm vs.
<0.9 mm) and incomplete proximal plaque coverage, type
of stent (closed vs. open cells) and aortic arch plaques
(complicated vs. uncomplicated).
Data analysis
First, we examined the differences in the prevalence of
>80% stent coverage and MES according to each potential
predictor using Fisher’s exact test for categorical variables
and Wilcoxon rank-sum test for continuous variables.
Second, the independent association between each poten-
tial determinant and >80% stent coverage or MES was
investigated using stepwise forward logistic regression.
Variables were included in the final models if clinicallyrelevant, reporting a p-value of <0.1 or changing the odds
ratio of significant predictors more than 10%. The goodness-
of-fit of both the models was checked using the Hosmere
Lemeshow test, and their predictive power assessed through
c-statistics (area under the receiving operator curve).
Statistical significance was defined as a two-sided p-value of
<0.05, and all analyses were carried out using STATA, version
10.0 (Stata Corp., College Station, TX, 2007).
The study protocol was informally approved by our
departmental review board (application for formal approval
by the institutional committee is not contemplated by an
institutional ethical committee for this sort of study design).
Results
This study included 68 patients. Epidemiology of this group is
summarised in Table 1 and reflects the usual distribution for
this type of patients. The patients included in this series had
100% technical success rate and 0% mortality and morbidity.
Neo-intimal progression
Among the 68 CASs examined (40 closed cells and 28 open
cells), in 52 cases the stent was covered by neo-intima for
more than80% of its surface (76.4%) after 6 months (Figs. 1, 2)
Table 5 Logistic regression models predicting complete stent coverage and late cerebral micro-embolism
Complete stent coverage Micro-embolisma
OR (95% CI) p* OR (95% CI) p*
Age (1-year increment) 1.06 (0.90e1.25) 0.5 0.77 (0.60e0.99) 0.039
Complicated aortic arch NI e e 7.96 (1.73e36.7) 0.008
Hypertension 0.12 (0.03e0.46) 0.002 NI e e
Carotid thickness NP e e NI e e
ORZ odds ratio; 95% CIZ 95% confidence interval. NIZ not included (not significant at both multivariate and bivariate analyses; age
was forced to enter in every model). NPZ not possible to evaluate as it predicted success perfectly. *HosmereLemeshow goodness-of-
fit p> 0.05 and area under the ROC curve >0.70 for both models.
a For 10 patients, it was not possible to determine the micro-embolism pattern.
Cerebral Embolism and Stent Coverage 523according to duplex scanning. In the remaining 16 (23.6%)
cases, the stent was only partially covered by scattered islets
of pseudo-intima, leaving the cells of the stent well visible
(Figs. 3, 4). Analysis of the peak systolic and end diastolic
velocities did not show any significant increase compared to
the normal values.17
Hypertensive patients had a greater incidence of
complete coverage (88.5% vs. 50%, pZ 0.002) and also
diabetes was associated with a favourable trend (23.1% vs.
0%, pZ 0.055). All the patients with a neo-intimal layer of
the stent >80% had total proximal plaque coverage by the
stent and a common carotid intimal layer <0.9 mm,
whereas patients with common carotid intimal thickness
>0.9 mm or incomplete plaque coverage did not show
a complete neo-intimal layer of the stent in any case
(p< 0.001) (Table 2) (Fig. 3).
Late micro-embolic events
TCD could be performed in only 58 of the 68 (85.3%) cases
due to the lack of an adequate acoustic window in 10
patients. MESs were recorded in 16 patients (27.6%),
including eight patients with MES and eight patients with
more than three ‘bursts’. The only characteristic associ-
ated with this phenomenon was the presence of a compli-
cated aortic arch plaque, which was present in 62.5% of
patients with MES vs. 23.8% of patients with no MES
(pZ 0.012) (Table 3). The characteristics associated with
complicated aortic arch plaque are summarised in Table 4.
At the logistic regression analysis, the presence of
complicated aortic arch and age turned out to be inde-
pendent predictors of MES (Table 5). There was no statis-
tical correlation between MES and neo-intimal stent
coverage.
Discussion
The first relevant finding of the present study is the
observation that carotid stents can be rapidly covered by
a new pseudo-intimal layer. Despite a wide body of litera-
ture available on mid- and long-term results of CAS,13,18e21
the remodelling of the stent structure by a new intimal
layer has not been reported earlier. The use of a new type
of sensitive duplex scanning allowed us to easily obtain
a clear image of the covering process, with subsequent
confirmation by 3D reconstruction.Data of the present study provide some pathophysio-
logical insight into the complex and still incompletely
understood process of stent coverage. The observation that
the new inner stent layer can be observed only if
a complete proximal coverage of the atherosclerotic plaque
is achieved and if the common carotid artery is unaffected
leads to the hypothesis of an endothelial migration from
the intima of a healthy segment of the common carotid
artery. An unexpected observation standing out from the
logistic regression analysis is the apparently favourable role
of hypertension; indeed, a history of hypertension seems to
be independently associated with stent healing. Our data
do not provide us with a clear explanation of this para-
doxical and intriguing result; therefore, further studies on
larger series are needed.
The second aim of our study was to investigate risk
factors for late cerebral embolism. Our study confirms that,
using standard methods described in the literature,5 late
asymptomatic cerebral micro-embolism occurs even after
successful CAS in more than a quarter of cases. The
significance of MES in the clinical setting is debated.15,16,22e
25 Although MESs by themselves are asymptomatic subclin-
ical phenomena, an epidemiological link with cerebral
ischaemic episodes and worsening of cognitive function
after surgery has been suggested.24 In our study, the
complete absence of neurological clinical events and the
lack of systematic cerebral MRI or TC evaluation precluded
the assessment of the clinical implications of MES.
In our series, patient age and the presence of compli-
cated aortic arch plaques were the only independent
determinants of these events, whereas completeness of
carotid plaque coverage and stent healing apparently were
not risk factors for these subclinical phenomena. Since age
of the patient is a known cause of increased aortic arch
disease and tortuosity,21 this association is not unexpected.
The link between complex aortic atherosclerosis and MES
found in the present study is in keeping with previous
observations on the role of atherosclerotic plaques as an
incremental risk factor for recurrent stroke.22e24 Further-
more, TEE-detected aortic atherosclerosis has been docu-
mented as a risk factor for asymptomatic cerebral
embolism in patients with tortuous carotid arteries and
aortic arch undergoing CAS.17 In the literature, possible
sources of MES other than carotid arteries and aortic arch
are reported, including prosthetic valves, the left atrium
(in patients with atrial fibrillation) and various catheter
procedures.11,26
524 G.L. Faggioli et al.In conclusion, despite the frequent, complete and rapid
neo-intimal healing of well-executed CAS, late cerebral
embolism continues to occur in patients with severe aortic
arch atherosclerosis, thus further underlining the impor-
tance of a complete clinical assessment of the patient with
carotid disease.
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